{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:19:53Z","timestamp":1783408793646,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007594","name":"Comenius University in Bratislava","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007594","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Subclinical impulsive\u2013compulsive behaviors (s-ICBs) in Parkinson\u2019s disease (PD) are common, clinically relevant, and frequently underdiagnosed. Objective behavioral measures reflecting vulnerability to impulsive\u2013compulsive behavior are lacking. We investigated whether oculomotor measures of inhibitory control are associated with s-ICBs in dopaminergically treated PD patients without clinically manifest impulse control disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-nine patients with PD (Hoehn and Yahr stages 1\u20132) and twenty age-matched healthy controls completed prosaccade and antisaccade eye-tracking tasks. Executive functioning, trait impulsivity, quality of life and s-ICBs were assessed. Group comparisons and association analyses were performed using nonparametric methods with false discovery rate correction. Exploratory mediation analysis examined relationships between levodopa equivalent daily dose (LEDD), s-ICBs severity, and express prosaccades. All assessments were performed in the ON-medication state.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with healthy controls, patients with PD showed a higher frequency of express prosaccades and prolonged antisaccade latencies. Within the PD group, express prosaccades were moderately to strongly associated with s-ICBs severity and LEDD and were also related to reduced quality of life. Mediation analysis revealed a significant statistical indirect effect of dopaminergic medication on express prosaccades through s-ICBs severity, indicating that behavioral symptoms statistically accounted for a substantial proportion of this association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings demonstrate a close relationship between oculomotor control, subclinical impulsive\u2013compulsive behaviors, and dopaminergic treatment in PD. The results highlight the complexity of non-motor manifestations in PD and underscore the need for longitudinal and mechanistic studies to clarify their clinical significance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10072-026-09177-z","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:07:25Z","timestamp":1781842045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reflexive eye movement alterations are related to subclinical impulsive-compulsive behaviors in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Lenka","family":"Hapakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Straka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Necpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Kusnirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavol","family":"Martis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6390-0872","authenticated-orcid":false,"given":"Zuzana","family":"Kosutzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"9177_CR1","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1016\/S1353-8020(09)70794-1","volume":"15","author":"D Weintraub","year":"2009","unstructured":"Weintraub D (2009) Impulse control disorders in Parkinson\u2019s disease: prevalence and possible risk factors. Parkinsonism Relat Disord 15:S110\u2013S113. https:\/\/doi.org\/10.1016\/S1353-8020(09)70794-1","journal-title":"Parkinsonism Relat Disord"},{"key":"9177_CR2","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1007\/s00415-023-11904-x","volume":"270","author":"I Pachi","year":"2023","unstructured":"Pachi I, Papadopoulos V, Xenaki LA, Koros C, Simitsi AM, Bougea A et al (2023) Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson\u2019s disease. J Neurol 270:5773\u20135783. https:\/\/doi.org\/10.1007\/s00415-023-11904-x","journal-title":"J Neurol"},{"key":"9177_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/mds.23501","volume":"26","author":"A Antonini","year":"2011","unstructured":"Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M et al (2011) Impulsivity and compulsivity in drug-na\u00efve patients with Parkinson\u2019s disease. Mov Disord 26:464\u2013468. https:\/\/doi.org\/10.1002\/mds.23501","journal-title":"Mov Disord"},{"key":"9177_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.14802\/jmd.19004","volume":"12","author":"D-W Ryu","year":"2019","unstructured":"Ryu D-W, Kim J-S, Yoo S-W, Oh Y-S, Lee K-S (2019) The Impact of Impulsivity on Quality of Life in Early Drug-Na\u00efve Parkinson\u2019s Disease Patients. J Mov Disord 12:172\u2013176. https:\/\/doi.org\/10.14802\/jmd.19004","journal-title":"J Mov Disord"},{"key":"9177_CR5","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/mdc3.13839","volume":"10","author":"F Giovannelli","year":"2023","unstructured":"Giovannelli F, Gavazzi G, Noferini C, Palumbo P, Viggiano MP, Cincotta M (2023) Impulsivity Traits in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis. Mov Disord Clin Pract 10:1448\u20131458. https:\/\/doi.org\/10.1002\/mdc3.13839","journal-title":"Mov Disord Clin Pract"},{"key":"9177_CR6","doi-asserted-by":"crossref","unstructured":"Martini A, Dal Lago D, Edelstyn NMJ, Grange JA, Tamburin S. Impulse Control Disorder in Parkinson\u2019s Disease: A Meta-Analysis of Cognitive, Affective, and Motivational Correlates. Frontiers in Neurology [Internet]. 2018 [cited 2024 Feb 12];9. https:\/\/www.frontiersin.org\/journals\/neurology\/articles\/10.3389\/fneur.2018.00654. Accessed 12 Feb 2024","DOI":"10.3389\/fneur.2018.00654"},{"key":"9177_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.tics.2004.02.010","volume":"8","author":"AR Aron","year":"2004","unstructured":"Aron AR, Robbins TW, Poldrack RA (2004) Inhibition and the right inferior frontal cortex. Trends Cogn Sci 8:170\u2013177. https:\/\/doi.org\/10.1016\/j.tics.2004.02.010","journal-title":"Trends Cogn Sci"},{"key":"9177_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105915","author":"L-M Dina","year":"2024","unstructured":"Dina L-M, Smith TJ, Hauser TU, Dommett EJ (2024) Naturalistic assessments across the lifespan: Systematic review of inhibition measures in ecological settings. Neurosci Biobehav Rev. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105915. 167:None","journal-title":"Neurosci Biobehav Rev"},{"key":"9177_CR9","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1016\/j.neuropsychologia.2008.07.002","volume":"46","author":"S van Stockum","year":"2008","unstructured":"van Stockum S, MacAskill M, Anderson T, Dalrymple-Alford J (2008) Don\u2019t look now or look away: two sources of saccadic disinhibition in Parkinson\u2019s disease? Neuropsychologia 46:3108\u20133115. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2008.07.002","journal-title":"Neuropsychologia"},{"key":"9177_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cortex.2024.06.005","volume":"178","author":"L Hapakova","year":"2024","unstructured":"Hapakova L, Necpal J, Kosutzka Z (2024) The antisaccadic paradigm: A complementary neuropsychological tool in basal ganglia disorders. Cortex 178:116\u2013140. https:\/\/doi.org\/10.1016\/j.cortex.2024.06.005","journal-title":"Cortex"},{"key":"9177_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrn1345","volume":"5","author":"DP Munoz","year":"2004","unstructured":"Munoz DP, Everling S (2004) Look away: the anti-saccade task and the voluntary control of eye movement. Nat Rev Neurosci Nat Publishing Group 5:218\u2013228. https:\/\/doi.org\/10.1038\/nrn1345","journal-title":"Nat Rev Neurosci Nat Publishing Group"},{"key":"9177_CR12","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.neuroimage.2012.01.057","volume":"60","author":"IGM Cameron","year":"2012","unstructured":"Cameron IGM, Pari G, Alahyane N, Brien DC, Coe BC, Stroman PW et al (2012) Impaired executive function signals in motor brain regions in Parkinson\u2019s disease. NeuroImage 60:1156\u20131170. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.01.057","journal-title":"NeuroImage"},{"key":"9177_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/jnnp.2006.099754","volume":"78","author":"AJ Hood","year":"2007","unstructured":"Hood AJ, Amador SC, Cain AE, Briand KA, Al-Refai AH, Schiess MC et al (2007) Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 78:565\u2013570. https:\/\/doi.org\/10.1136\/jnnp.2006.099754","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9177_CR14","doi-asserted-by":"publisher","first-page":"108082","DOI":"10.1016\/j.neuropsychologia.2021.108082","volume":"163","author":"J Waldthaler","year":"2021","unstructured":"Waldthaler J, Stock L, Kr\u00fcger-Zechlin C, Timmermann L (2021) Age at Parkinson\u2019s disease onset modulates the effect of levodopa on response inhibition: Support for the dopamine overdose hypothesis from the antisaccade task. Neuropsychologia 163:108082. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2021.108082","journal-title":"Neuropsychologia"},{"key":"9177_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.clinph.2013.06.188","volume":"125","author":"S Cubizolle","year":"2014","unstructured":"Cubizolle S, Damon-Perri\u00e8re N, Dupouy S, Foubert-Samier A, Tison F (2014) Parkinson\u2019s disease, l-Dopa and express saccades: Superior colliculus dyskinesias? Clin Neurophysiol 125:647\u2013648. https:\/\/doi.org\/10.1016\/j.clinph.2013.06.188","journal-title":"Clin Neurophysiol"},{"key":"9177_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3233\/JPD-181460","volume":"9","author":"P Barbosa","year":"2019","unstructured":"Barbosa P, Kaski D, Castro P, Lees AJ, Warner TT, Djamshidian A (2019) Saccadic Direction Errors are Associated with Impulsive Compulsive Behaviours in Parkinson\u2019s Disease Patients. J Parkinsons Dis 9:625\u2013630. https:\/\/doi.org\/10.3233\/JPD-181460","journal-title":"J Parkinsons Dis"},{"key":"9177_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40263-024-01087-y","volume":"38","author":"F Carbone","year":"2024","unstructured":"Carbone F, Djamshidian A (2024) Impulse Control Disorders in Parkinson\u2019s Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management. CNS Drugs 38:443\u2013457. https:\/\/doi.org\/10.1007\/s40263-024-01087-y","journal-title":"CNS Drugs"},{"key":"9177_CR18","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","volume":"38","author":"ST Jost","year":"2023","unstructured":"Jost ST, Kaldenbach M-A, Antonini A, Martinez-Martin P, Timmermann L, Odin P et al (2023) Levodopa Dose Equivalency in Parkinson\u2019s Disease: Updated Systematic Review and Proposals. Mov Disord 38:1236\u20131252. https:\/\/doi.org\/10.1002\/mds.29410","journal-title":"Mov Disord"},{"key":"9177_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Mamikonyan E, Papay K, Shea JA, Xie SX, Siderowf A (2012) Questionnaire for Impulsive-Compulsive Disorders in Parkinson\u2019s Disease\u2013Rating Scale. Mov Disord 27:242\u2013247. https:\/\/doi.org\/10.1002\/mds.24023","journal-title":"Mov Disord"},{"key":"9177_CR20","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s00415-014-7299-6","volume":"261","author":"CC Probst","year":"2014","unstructured":"Probst CC, Winter LM, M\u00f6ller B, Weber H, Weintraub D, Witt K et al (2014) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease (QUIP) and the QUIP-rating scale in a German speaking sample. J Neurol 261:936\u2013942. https:\/\/doi.org\/10.1007\/s00415-014-7299-6","journal-title":"J Neurol"},{"key":"9177_CR21","unstructured":"Hajd\u00fak M, Brandoburov\u00e1 P, Pribi\u0161ov\u00e1 K, Abrah\u00e1mov\u00e1 M, Cvikov\u00e1 V, Dan\u010d\u00edk D, Gergely S, Krakovsk\u00e1 S, Mali\u0161ov\u00e1 E, Svingerov\u00e1 A, Heretik A, Heretik AM (2020) Neuropsy: \u0161tandardiz\u00e1cia neuropsychologickej testovej bat\u00e9rie na dospelej slovenskej popul\u00e1cii. Univerzita Komensk\u00e9ho v Bratislave. ISBN 9788022350655"},{"key":"9177_CR22","doi-asserted-by":"publisher","first-page":"e209609","DOI":"10.1212\/WNL.0000000000209609","volume":"103","author":"CB Young","year":"2024","unstructured":"Young CB, Cholerton B, Smith AM, Shahid-Besanti M, Abdelnour C, Mormino EC et al (2024) The Parkinson\u2019s Disease Composite of Executive Functioning. Neurol Wolters Kluwer 103:e209609. https:\/\/doi.org\/10.1212\/WNL.0000000000209609","journal-title":"Neurol Wolters Kluwer"},{"key":"9177_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1037\/a0031542","volume":"120","author":"TV Wiecki","year":"2013","unstructured":"Wiecki TV, Frank MJ (2013) A computational model of inhibitory control in frontal cortex and basal ganglia. Psychol Rev US: Am Psychol Association 120:329\u2013355. https:\/\/doi.org\/10.1037\/a0031542","journal-title":"Psychol Rev US: Am Psychol Association"},{"key":"9177_CR24","doi-asserted-by":"publisher","first-page":"fcad049","DOI":"10.1093\/braincomms\/fcad049","volume":"5","author":"HC Riek","year":"2023","unstructured":"Riek HC, Brien DC, Coe BC, Huang J, Perkins JE, Yep R et al (2023) Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseases. Brain Commun 5:fcad049. https:\/\/doi.org\/10.1093\/braincomms\/fcad049","journal-title":"Brain Commun"},{"key":"9177_CR25","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.neuropsychologia.2011.03.002","volume":"49","author":"Y Terao","year":"2011","unstructured":"Terao Y, Fukuda H, Yugeta A, Hikosaka O, Nomura Y, Segawa M et al (2011) Initiation and inhibitory control of saccades with the progression of Parkinson\u2019s disease \u2013 Changes in three major drives converging on the superior colliculus. Neuropsychologia 49:1794\u20131806. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2011.03.002","journal-title":"Neuropsychologia"},{"key":"9177_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neuroimage.2012.11.036","volume":"68","author":"J Hirschmann","year":"2013","unstructured":"Hirschmann J, \u00d6zkurt TE, Butz M, Homburger M, Elben S, Hartmann CJ et al (2013) Differential modulation of STN-cortical and cortico-muscular coherence by movement and levodopa in Parkinson\u2019s disease. NeuroImage 68:203\u2013213. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.11.036","journal-title":"NeuroImage"},{"key":"9177_CR27","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.celrep.2015.09.046","volume":"13","author":"AD Bolton","year":"2015","unstructured":"Bolton AD, Murata Y, Kirchner R, Kim S-Y, Young A, Dang T et al (2015) A Diencephalic Dopamine Source Provides Input to the Superior Colliculus, where D1 and D2 Receptors Segregate to Distinct Functional Zones. Cell Rep 13:1003\u20131015. https:\/\/doi.org\/10.1016\/j.celrep.2015.09.046","journal-title":"Cell Rep"},{"key":"9177_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.0241","volume":"30","author":"R Cools","year":"2006","unstructured":"Cools R (2006) Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson\u2019s disease. Neurosci Biobehav Rev 30:1\u201323. https:\/\/doi.org\/10.1016\/j.neubiorev.2005.03.0241","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"9177_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1212\/CPJ.0b013e318278be9","volume":"2","author":"HD Weiss","year":"2012","unstructured":"Weiss HD, Marsh L (2012) Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease. Neurol Clin Pract 2(4):267\u2013274. https:\/\/doi.org\/10.1212\/CPJ.0b013e318278be9b PubMed PMID: 23634371; PubMed Central PMCID: PMC3613210","journal-title":"Neurol Clin Pract"},{"key":"9177_CR30","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3233\/JPD-230372","volume":"14","author":"A Demailly","year":"2024","unstructured":"Demailly A, Moreau C, Devos D (2024) Effectiveness of Continuous Dopaminergic Therapies in Parkinson\u2019s Disease: A Review of L-DOPA Pharmacokinetics\/Pharmacodynamics. J Parkinsons Dis 14:925\u2013939. https:\/\/doi.org\/10.3233\/JPD-230372","journal-title":"J Parkinsons Dis"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09177-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09177-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09177-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:02:12Z","timestamp":1783407732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09177-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["9177"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09177-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of University Hospital Bratislava. Institutional Review Board approval was obtained on March 17, 2022 (approval No. 10\/2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"578"}}